Adarotene

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAdarotene
Drug Alias Name阿达罗汀adarotenumadarotenoST-1926AHPC
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoid X receptor agonistsRetinoic acid receptors agonists
TargetsRetinoid X receptorRetinoic acid receptors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSigma-Tau Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSigma-Tau Spa
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksWikipedia